VASH1 and breast cancer: These data show that both MDA-MB-231 and Hs578t breast cancer cells that express either TCP-VASH1 or TCP-VASH2 degraded significantly more gelatin compared to those cells transfected with a control sfGFP vector (Figure 6B,D).